Healthcare

Wende Hutton

General Partner / West Coast

Since 2004

Wende identifies, builds and invests in companies that change medicine by bringing novel drugs, technologies and devices to market. She has partnered with founders to deliver more than a dozen of those innovations to patients. She started her venture career as a General Partner at Mayfield. She previously held senior marketing roles at GenPharm and Nellcor. Wende holds an A.B. in human biology from Stanford University and an M.B.A. from Harvard Business School.

Wende in 5

Travel: City sights followed by outdoor adventure days – perfect combo

Origins: Stints in Asia & Europe but I never leave my native Bay Area for long

Giving: Global health & preserving the environment

Sport: Hiking, biking, skiing, sailing & the list goes on…

Dream Job: Field biologist working on broad scale conservation

Investments

Current

Previous

  • Alsius Corporation
    Acquired by Zoll
  • Apieron
    Acquired by Aerocrine
  • BiPar Sciences, Inc.
    Acquired by Sanofi-Aventis
  • Calibra Medical
    Acquired by LifeScan / Johnson & Johnson
  • Chimerix
    IPO
  • Dermira
    IPO
  • Labrys Biologics
    Acquired by Teva Pharmaceutical
  • Northstar Neuroscience
    IPO
  • Transcend Medical
    Acquired by Alcon / Novartis

Latest

FierceBiotech: Glooko makes its management app free to any person with diabetes

BioCentury: Wende Hutton on mapping microbiome manufacturing

Business Insider: Wende Hutton and top VCs give their best 2019 predictions for healthcare

SF Business Times: Antiva CEO draws on personal experience to fuel drug development

BioCentury: Sweet switch - Glooko & Novo Nordisk A/S partner on diabetes monitoring app

STAT News: Antiva tried to drum up interest for a much-needed drug. Many men didn’t get it

Endpoints: Virtual biotech Antiva sets out on a big R&D quest, armed with a $22 million round for an HPV therapy

Spotlight on Wende Hutton’s 25 years in venture capital

Business Insider: Wende Hutton who’s worked in venture capital for 25 years shares her best career advice — and why it was worth being the first and only woman on her team when she started out

C&EN: Investment flows at J.P. Morgan Healthcare Conference

Endpoints News: Six top biotech VCs take a look at the latest trends, and offer their thoughts on 2018

CNBC: 11 women who prove that health tech investing isn’t a boys’ club

Fierce Biotech: Canaan unveils $800 million fund for fresh wave of biotech bets

Women of Venture in Healthcare: 30x return on investment . . . in each other

TechCrunch: Diabetes management platform Glooko raises $35 million

Biotech NOW: Invest in diversity to drive innovation

Fierce Biotech: “Synthetic cartilage” startup raises Hyalex reels in $16 million

Body Politic Series: Women's access to healthcare

Wende in 5

Travel: City sights followed by outdoor adventure days – perfect combo

Origins: Stints in Asia & Europe but I never leave my native Bay Area for long

Giving: Global health & preserving the environment

Sport: Hiking, biking, skiing, sailing & the list goes on…

Dream Job: Field biologist working on broad scale conservation